Source:http://linkedlifedata.com/resource/pubmed/id/15715433
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2005-2-17
|
| pubmed:abstractText |
Several independent population studies have reported that the apolipoprotein C3 (APOC3) Sst I polymorphism in apolipoprotein (apo) A1 /C3/A4/A5 gene cluster is associated with Hypertriglyceridaemia (HTG). HTG is a known risk factor for coronary atherosclerotic heart disease(CHD)and type II diabetes mellitus (non-insulin-dependent diabetes, NIDDM). The aim of this study is to investigate the association between the APOC3 gene Sst I polymorphism and the hypertriglyceridaemia in CHD and NIDDM in Chinese population. The genotype and allele frequencies of APOC3 Sst I polymorphism (S1/S2) were analyzed by PCR-restriction fragment length polymorphism in 267 CHD patients, 246 NIDDM patients and 491 unrelated healthy control individuals. The frequencies of minor allele 52 in CHD group, NIDDM group and control group were 0.301, 0.307 and 0.286, respectively. Compared with controls, there was no significant difference in distribution of genotype and allele frequencies of Sst I polymorphic site in CHD patients and NIDDM patients, respectively. However, the frequency of S1 S2 genotype in the HTG subgroup was significantly higher than that of the normal triglyceridaemia subgroup (NTG) in CHD patients (0.542 > 0.357, chi2 = 8.77, P = 0.0124). In NIDDM patients, the frequency of S2 S2 genotype in the HTG subgroup was significantly high, compared with that in the NTG subgroup (0.200 > 0.055, chi2 = 20.21, P = 0.0000), and there was significantly difference in the distribution of allele frequencies in subgroups of NTG and HTG (chi2 = 19.86, P = 0.0000). The level of triglyceride (TG) in S1 S2 genotype patients of CHD group were higher than that of S1 S1 genotype patients (P = 0.036). In NIDDM and controls groups, S2 S2 genotype individuals exhibited a significant increase in plasma TG concentrations, respectively compared with S1 S1 and S1 S2 genotype individuals of each group (P < 0.01). The minor allele S2, which was associated with both CHD with HTG and NIDDM with HTG and may contribute to the susceptibility of hypertriglyceridemia in CHD and NIDDM patients, may be one of the genetic predispositions to both CHD with HTG and NIDDM with HTG in Chinese population.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0379-4172
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
32
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
11-8
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:15715433-Aged,
pubmed-meshheading:15715433-Apolipoprotein C-III,
pubmed-meshheading:15715433-Asian Continental Ancestry Group,
pubmed-meshheading:15715433-China,
pubmed-meshheading:15715433-Cholesterol, LDL,
pubmed-meshheading:15715433-Coronary Artery Disease,
pubmed-meshheading:15715433-Diabetes Mellitus, Type 2,
pubmed-meshheading:15715433-Female,
pubmed-meshheading:15715433-Gene Frequency,
pubmed-meshheading:15715433-Genetic Predisposition to Disease,
pubmed-meshheading:15715433-Genotype,
pubmed-meshheading:15715433-Humans,
pubmed-meshheading:15715433-Hypertriglyceridemia,
pubmed-meshheading:15715433-Male,
pubmed-meshheading:15715433-Middle Aged,
pubmed-meshheading:15715433-Polymerase Chain Reaction,
pubmed-meshheading:15715433-Polymorphism, Genetic,
pubmed-meshheading:15715433-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:15715433-Triglycerides
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population.
|
| pubmed:affiliation |
Department of Medical Genetics, West China Hospital, Sichuan University, the State Key Laboratory of Biotherapy of Human Disease, Chengdu 610041, China. fjlhk@163.com
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|